(Press-News.org) A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics.
Eosinophilic asthma is characterized by high levels of eosinophils, a type of white blood cell involved in the body’s immune response. While eosinophils typically help fight infections, in eosinophilic asthma, they accumulate in the lungs and airways, causing chronic inflammation, swelling and damage to the respiratory system.
Eosinophilic asthma is driven by type 2 (T2) inflammation, an immune response involving cytokines that promote the production and activation of eosinophils. Because of this, therapies targeting T2 inflammation are used to reduce eosinophil levels and prevent asthma flare-ups.
But even with targeted therapies against T2 inflammation, some children still experience asthma attacks. This suggests that other inflammatory pathways also play a role in exacerbations, said Rajesh Kumar, MD, Interim Division Head of Allergy and Immunology at Ann & Robert H. Lurie Children’s Hospital of Chicago, who was a co-author of the paper.
In the study, scientists analyzed data from a previous clinical trial studying respiratory illnesses in children with eosinophilic asthma living in low-income urban areas across nine U.S. cities. Investigators compared the effects of mepolizumab—a biologic therapy that targets T2 inflammation—with a placebo over a 52-week period.
While mepolizumab significantly reduced the expression of eosinophil-associated T2 inflammation during asthma flare-ups, exacerbations still occurred.
“The previous trial raised questions about what happens when you take away some of the allergic inflammation using a biologic drug, and why is it that some children experience exacerbations and some don't?” Dr. Kumar said. “Different types of inflammation–allergic and different types of nonallergic inflammation–interact with exacerbations, both viral and non-viral. We wanted a more precise way of understanding what's driving some of the exacerbations in kids.”
By employing RNA sequencing of nasal samples collected during 176 episodes of acute respiratory illness, investigators identified three distinct inflammatory drivers of asthma exacerbations. The first were epithelial inflammatory pathways, which were increased in children receiving mepolizumab, regardless of viral infection. The second was macrophage-driven inflammation, which was specifically linked to viral respiratory illnesses, and the third involved mucus hypersecretion and cellular stress responses, which were elevated in both treatment and placebo groups during flare-ups.
“We found that children who still exacerbated on the drug had less of this allergic type of inflammation, but they had other residual epithelial pathways which were driving some of that inflammatory response that was involved in exacerbation,” Dr. Kumar said.
The study highlights the complexity of asthma in children and underscores the need for more personalized treatment strategies, Dr. Kumar said.
“There are multiple different types of inflammatory responses that are involved in exacerbations, and they're driving exacerbations differentially based on whether patients have a virus or are taking drugs to block different parts of the inflammatory response,” Dr. Kumar said.
As asthma continues to affect children in urban communities disproportionately, the insights from the study could pave the way for precision interventions for children based on the type of inflammation driving their asthma, and lead to improved quality of life for young patients, Dr. Kumar said.
“This study gives us a better understanding of what results in persistent exacerbations and opens up the potential for new therapies or combinations of therapies based upon that.”
The study was supported by a National Institutes of Health grant (UM1AI11427).
Ann & Robert H. Lurie Children’s Hospital of Chicago is a nonprofit organization committed to providing access to exceptional care for every child. It is the only independent, research-driven children’s hospital in Illinois and one of less than 35 nationally. This is where the top doctors go to train, practice pediatric medicine, teach, advocate, research and stay up to date on the latest treatments. Exclusively focused on children, all Lurie Children’s resources are devoted to serving their needs. Research at Lurie Children’s is conducted through Stanley Manne Children’s Research Institute, which is focused on improving child health, transforming pediatric medicine and ensuring healthier futures through the relentless pursuit of knowledge. Lurie Children’s is the pediatric training ground for Northwestern University Feinberg School of Medicine. It is ranked as one of the nation’s top children’s hospitals by U.S. News & World Report.
END
Study reveals hidden drivers of asthma flare-ups in children
2025-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Physicists decode mysterious membrane behavior
2025-08-01
Cell membranes cradle, protect, and gatekeep living cells. Membranes can even affect how a cell behaves.
But membranes’ own erratic behavior has puzzled scientists for years.
Turns out, it’s all about perspective: When physicist Rana Ashkar’s team members looked at how membranes behave on the nanoscale, they were able to identify unified biophysical laws that membranes have adhered to all along.
Published in Nature Communications, these findings have significant implications for disease ...
New insights about brain receptor may pave way for next-gen mental health drugs
2025-08-01
New York, NY [August 1, 2025]— In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights into how a critical brain receptor works at the molecular level and why that matters for mental health treatments.
The study, published in the August 1 online issue of Science Advances, focuses on the 5-HT1A serotonin receptor, a major player in regulating mood and a common target of both traditional antidepressants and newer therapies such as psychedelics. Despite its ...
Melanoma ‘sat-nav’ discovery could help curb metastasis
2025-08-01
Researchers have discovered a protein which is critical for steering melanoma cancer cells as they spread throughout the body. The malignant cells become dependent on this protein to migrate, pointing to new strategies for impeding metastasis.
The protein eIF2A is generally thought to spring into action when a cell is under stress, helping ribosomes launch protein synthesis. But according to a study published today in the journal Science Advances, eIF2A has a completely different role in melanoma, helping cancerous cells control movement.
“Malignant cells that metastasize ...
When immune commanders misfire: new insights into rheumatoid arthritis inflammation
2025-08-01
Researchers at Kyoto University have discovered that an immune molecule found only in primates, called IGFL2, plays a key role in regulating inflammation in rheumatoid arthritis (RA). IGFL2 is produced by a subset of immune cells in the joints of patients with RA and acts like fuel on a fire: it activates more immune cells, further amplifying inflammation and worsening joint damage. They also found that IGFL2 levels were much higher in the blood of patients with RA, especially in those with more severe symptoms. These findings support IGFL2’s potential as a diagnostic marker, a tool for monitoring disease progression, ...
SFU researchers develop a new tool that brings blender-like lighting control to any photograph
2025-08-01
Lighting plays a crucial role when it comes to visual storytelling. Whether it’s film or photography, creators spend countless hours, and often significant budgets, crafting the perfect illumination for their shot. But once a photograph or video is captured, the illumination is essentially fixed. Adjusting it afterward, a task called “relighting,” typically demands time-consuming manual work by skilled artists.
While some generative AI tools attempt to tackle this task, they rely on large-scale neural networks and billions of training images to guess how light might interact with a scene. But the process is often ...
Pups in tow, Yellowstone-area wolves trek long distances to stay near prey
2025-08-01
Berkeley — Gray wolf pups are born nearly helpless: blind, deaf and lacking the acute sense of smell of their elders. They usually remain in the safe confines of their den until they are at least three weeks old.
That is why UC Berkeley biologists were surprised to observe gray wolves near Yellowstone National Park traveling 20 kilometers or more over rugged, mountainous terrain, with very young pups in tow.
“The first time I saw a camera trap photo of a wolf carrying its pup, I just cracked up because the pup is being carried by its butt,” said Avery Shawler, first author of a new study presenting the findings, which appeared ...
AI breakthrough unlocks 'new' materials to replace lithium-ion batteries
2025-08-01
Researchers from New Jersey Institute of Technology (NJIT) have used artificial intelligence to tackle a critical problem facing the future of energy storage: finding affordable, sustainable alternatives to lithium-ion batteries.
In research published in Cell Reports Physical Science, the NJIT team led by Professor Dibakar Datta successfully applied generative AI techniques to rapidly discover new porous materials capable of revolutionizing multivalent-ion batteries. These batteries, using abundant elements like magnesium, calcium, aluminum and zinc, offer a promising, cost-effective alternative to lithium-ion batteries, ...
Making molecules make sense: A regional explanation method reveals structure–property relationships
2025-08-01
In cheminformatics, where machine learning is transforming our understanding of how molecular properties are predicted and explained, a critical challenge has long remained: making these powerful but often "black box" models easier to interpret. Recently, researchers at the Australian National University developed a breakthrough solution: a "regional explanation" method that helps reveal how molecular structures drive their properties. This research was published June 3 in Intelligent ...
Partisan hostility, not just policy, drives U.S. protests
2025-08-01
Partisan animosity is a powerful driver of protest participation -- sometimes nearly matching or even exceeding concern about the actual issues, according to a new study published in the journal Social Forces.
The research, conducted by political scientist Seth Warner at the University of Connecticut, analyzed three nationally representative surveys fielded between 2014 and 2022. Each focused on a different protest movement: Black Lives Matter, the climate movement, and the Tea Party.
Warner matched survey questions to these movements’ core grievances ...
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025
2025-08-01
Reston, VA (August 1, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
New Imaging Tool Targets Hidden Liver Tumors
Liver cancer is hard to monitor after treatment, ...